NuVasive® is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine. The Company is the third largest medical device company in the $8.2 billion global spine market. NuVasive’s principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. Having redefined spine surgery with the MAS platform’s lateral approach, known as eXtreme Lateral Interbody Fusion, or XLIF®, NuVasive has built an entire spine franchise. With over 90 products today spanning lumbar, thoracic and cervical applications, the Company will continue to expand and evolve its offering predicated on its R&D focus and dedication to outstanding service levels supported by a culture of Absolute Responsiveness®.
Company Growth (employees)
San Diego, US
Size (employees)
2,200 (est)
NuVasive was founded in 1997 and is headquartered in San Diego, US

NuVasive Office Locations

NuVasive has offices in San Diego, Memphis, Columbia, Fairborn and in 9 other locations
San Diego, US (HQ)
7475 Lusk Blvd
Aliso Viejo, US
100 101 Enterprise
Columbia, US
250 10420 Little Patuxent Pkwy
Fairborn, US
1 Herald Square
Memphis, US
101 4670 E Shelby Dr
Kew, AU
620 High St
Show all (13)

NuVasive Financials and Metrics

NuVasive Financials

NuVasive's revenue was reported to be $962.1 m in FY, 2016

Revenue (Q3, 2017)

247.4 m

Gross profit (Q3, 2017)

181.8 m

Gross profit margin (Q3, 2017), %


Net income (Q3, 2017)

33.2 m

Market capitalization (11-Dec-2017)

3.1 b

Cash (30-Sep-2017)

62.2 m


3 b
NuVasive's current market capitalization is $3.1 b.
USDFY, 2013Y, 2014Y, 2015FY, 2016


685.2 m762.4 m811.1 m962.1 m

Revenue growth, %


Cost of goods sold

180.5 m182.4 m194.5 m240.1 m

Gross profit

504.7 m580.1 m616.6 m722 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


192.4 m202.9 m200.5 m215 b236.2 m239.6 m249.9 m260.6 m247.4 m

Cost of goods sold

45.7 m48.4 m49.2 m54.2 b59.7 m59.2 m61.6 m66.4 m65.6 m

Gross profit

146.7 m154.5 m151.4 m160.8 b176.5 m180.5 m188.3 m194.2 m181.8 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


102.8 m142.4 m192.3 m153.6 m


10.9 m21.6 m8.8 m208.2 m

Current Assets

536 m705.9 m702.8 m575.4 m


128.1 m128.6 m141.4 m181.5 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


100.6 m110.8 m106.5 m130.7 m88.5 m78.6 m141.3 m270.1 m263.1 m203.8 m134 m130.9 m62.2 m

Accounts Receivable

96.2 m


140.7 m147.7 m157.4 m159.7 m163.4 m163.7 m164.9 m200.7 m201.9 m212.8 m223.1 m236.8 m249 m

Current Assets

488 m606.3 m587.1 m629.6 m632.9 m684.3 m698.5 m692.2 m712 m616.9 m563.3 m592.2 m529.9 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

7 m(17.5 m)65.3 m35.4 m

Depreciation and Amortization

63.1 m65.8 m65.9 m42 m

Accounts Receivable

(17 m)(18 m)(9.5 m)(33.3 m)


(3.6 m)(5.2 m)1.2 m(22.6 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

31.4 m41.4 m54.2 m(9.3 m)26 m29.5 m12.3 m24.6 m57.7 m

Depreciation and Amortization

16.1 m32.6 m49 m21.2 m46.3 m73.8 m29.5 m58.7 m88.9 m

Accounts Receivable

5.9 m637 k2.2 m6.9 m(8.6 m)(3 m)924 k(17.6 m)(14.8 m)


157.4 m159.7 m(11.4 m)(15.2 m)(19.8 m)(9.4 m)(12 m)(22.4 m)(13.6 m)(29 m)(36.2 m)
USDY, 2017


25.6 x


112.5 k

Financial Leverage

2.1 x
Show all financial metrics

NuVasive Market Value History

NuVasive Median Salaries

Source: 31 public H-1B filings from NuVasive

NuVasive's Web-traffic and Trends

NuVasive Online and Social Media Presence

NuVasive News and Updates

World Artificial Disc Replacement Market is Growing at a CAGR of 15 % During Forecasted Period 2017-2023

Market Research Future published a half-cooked research report on global artificial disc replacement market, Global Artificial Disc Replacement Market Is Growing At A CAGR Of 15 % During Forecasted Period 2017-2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

NuVasive Company Life and Culture

You may also be interested in